F. Astruc-Diaz

发表

2,3‐Dihydro‐1‐Benzofuran Derivatives as a Series of Potent Selective Cannabinoid Receptor 2 Agonists: Design, Synthesis, and Binding Mode Prediction through Ligand‐Steered Modeling

Claudio N. Cavasotto, Sharangdhar S. Phatak, C. Cavasotto, 2009, ChemMedChem.

6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.

Sharangdhar S. Phatak, C. Cavasotto, P. Diaz, 2009, Journal of medicinal chemistry.

Pharmacological Characterization of a Novel Cannabinoid Ligand, MDA19, for Treatment of Neuropathic Pain

P. Diaz, Jijun Xu, F. Astruc-Diaz, 2010, Anesthesia and analgesia.

Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy

P. Diaz, F. Astruc-Diaz, M. Naguib, 2014, Neuroscience.

Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.

N. Guilloteau, F. Fronczek, N. Isoherranen, 2016, Journal of Medicinal Chemistry.

Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain

F. Astruc-Diaz, 2012 .

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models

P. Vivas-Mejia, P. Diaz, F. Astruc-Diaz, 2008, British journal of pharmacology.

In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7.

S. Parola, P. Diaz, Jijun Xu, 2013, Journal of pharmaceutical sciences.

Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors

Phillip H. Beske, F. Astruc-Diaz, T. Denton, 2021, Pharmaceutics.

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

P. Diaz, Jijun Xu, F. Astruc-Diaz, 2008, Journal of medicinal chemistry.

Identification of NADPH oxidase as a key mediator in the post‐ischemia‐induced sequestration and degradation of the GluA2 AMPA receptor subunit

Phillip H. Beske, F. Astruc-Diaz, D. Jackson, 2015, Journal of neurochemistry.

The Post-Ischemic Increase in GluA2 Ser880 Phosphorylation Involves NADPH Oxidase

Phillip H. Beske, F. Astruc-Diaz, D. Jackson, 2018, Journal of Pharmaceutics and Therapeutics.